aTyr Pharma granted additional 180-day period to cure minimum bid price deficiency
aTyr Pharma received notice on June 3, 2026 that it has until November 30, 2026 to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per…
$1.00June 3, 2026November 30, 2026